Halozyme Therapeutics (DE:RV7)
FRANKFURT:RV7

Halozyme (RV7) Similar Stocks

2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Agios Pharma
$2.65B
-7.39
69.37%
6 Buy
2 Hold
0 Sell
Strong Buy
$52.83
Alnylam Pharma
$30.08B
-88.65
23.66%
14 Buy
6 Hold
0 Sell
Moderate Buy
$267.58
Bluebird Bio
$202.38M
-1.41
-74.07%
3 Buy
3 Hold
1 Sell
Moderate Buy
$5.00
Crispr Therapeutics AG
$4.63B
-20.04
-3.82%
9 Buy
6 Hold
1 Sell
Moderate Buy
$78.36
Halozyme
€6.31B
22.35
26.38%
6 Buy
3 Hold
0 Sell
Moderate Buy
€53.02
Halozyme
$6.88B
22.35
26.38%
6 Buy
3 Hold
0 Sell
Moderate Buy
$57.75

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
AGIO
Agios Pharma
46.61
21.01
82.07%
ALNY
Alnylam Pharma
237.83
42.96
22.05%
BLUE
Bluebird Bio
1.05
-2.68
-71.85%
CRSP
Crispr Therapeutics AG
54.56
-0.88
-1.59%
DE:RV7
Halozyme
49.75
10.40
26.43%
HALO
Halozyme
54.04
10.53
24.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis